dc.creatorMendonca R.
dc.creatorGueiros L.A.
dc.creatorCapellaro K.
dc.creatorPinheiro V.R.P.
dc.creatorLopes M.P.
dc.date2011
dc.date2015-06-30T20:42:10Z
dc.date2015-11-26T14:53:50Z
dc.date2015-06-30T20:42:10Z
dc.date2015-11-26T14:53:50Z
dc.date.accessioned2018-03-28T22:05:42Z
dc.date.available2018-03-28T22:05:42Z
dc.identifier
dc.identifierIndian Journal Of Dental Research. , v. 22, n. 6, p. 869 - 870, 2011.
dc.identifier9709290
dc.identifier10.4103/0970-9290.94690
dc.identifierhttp://www.scopus.com/inward/record.url?eid=2-s2.0-84859761818&partnerID=40&md5=92a603a06ad19a1a21498db764f66c7a
dc.identifierhttp://www.repositorio.unicamp.br/handle/REPOSIP/108938
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/108938
dc.identifier2-s2.0-84859761818
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1255019
dc.descriptionHydroxyurea (HU) is an antimetabolic agent commonly used in myeloproliferative disorders and hematological diseases as well as in severe psoriasis. Despite of usually be well tolerated, sometimes it can induce immunosuppression and mucocutaneous adverse effects associated with discomfort or pain. Nevertheless, oral mucosal adverse reactions are extremely uncommon and present as ulcers, tongue depapilation and dyschromia. Complete remission of adverse effects is usually observed after withdrawal of the medication. The aim of this paper is to report two patients with oral lesions related to HU treatment. T0 he patients were adequately managed by changing hydroxyurea with imatinib mesilate. Oral lesions are rare complications of long-term hydroxyurea treatment and may be an indication of stopping therapy and substitution with imatinib mesilate.
dc.description22
dc.description6
dc.description869
dc.description870
dc.descriptionDe Benedittis, M., Petruzzi, M., Giardina, C., Lo Muzio, L., Favia, G., Serpico, R., Oral squamous cell carcinoma during long-term treatment with hydroxyurea (2004) Clin Exp Dermatol, 29, pp. 605-607
dc.descriptionTeo, R.Y., Tan, E., A case of hydroxyurea-induced transverse melanonychia (2006) Int J Dermatol, 45, pp. 1329-1330
dc.descriptionPamuk, G.E., Turgut, B., Vural, O., Demir, M., Tek, M., Altaner, S., Metastatic squamous cell carcinoma of the skin in chronic myeloid leukaemia: Complication of hydroxyurea therapy (2003) Clin Lab Haem, 25, pp. 329-331
dc.descriptionSaravu, K., Velappan, P., Lakshmi, N., Shastry, B.A., Thomas, J., Hydroxyurea induced perimalleolar ulcers (2006) J Korean Med Sci, 21, pp. 177-179
dc.descriptionNorhaya, M.R., Cheong, S.K., Ainoon, O., Hamidah, N.H., Painful oral ulcers with hydroxyurea therapy (1997) Singapore Med J, 38, pp. 283-284
dc.descriptionSanches-Palacios, C., Guitart, J., Hydroxyurea-associated squamous dysplasia (2004) J Am Acad Dermatol, 51, pp. 293-300
dc.descriptionBrincker, H., Christensen, B.E., Acute mucocutaneous toxicity following high-dose hydroxyurea (1993) Can Chem Pharm, 32, pp. 496-497
dc.languageen
dc.publisher
dc.relationIndian Journal of Dental Research
dc.rightsaberto
dc.sourceScopus
dc.titleOral Lesions Associated With Hydroxyurea Treatment
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución